The trends on Gift Nifty also indicate a negative start for the Indian benchmark index. The Gift Nifty was trading around 23,583 level, a discount of nearly 63 points from the Nifty futures’ previous close.

Indian benchmark indices Nifty 50 and Sensex ended in the red. Nifty 50 closed at 23,526.50, while Sensex ended at 77,620.21.TCS, IREDA, Mahanagar as, MAzagon Dock, Polyplex Corporation, Tata Elexsi,

Indian benchmark indices are trading lower at noon. Both Nifty and Sensex are down 0.6%. The benchmark Nifty 50 will see volatility on Thursday's weekly expiry.

For benchmark Nifty-50 index, 23650 will be the key level to watch. Below this level, the market could continue its weak formation till 23400-23375. Conversely, if it rises above 23650, it could bounce back to 23750-23800,

Indian equity markets fell on Thursday, January 09. The BSE Sensex dropped as much as 0.77% to 77,542.92 level while the NSE compiled Nifty 50 slipped 0.78% to an intra-day low level of 23,503, testing one of the important support levels. The Nifty 50 closed the session 0.69% lower at 23,526.50. The Sensex dropped 0.68% to finish at 77,620.21.

The Indian stock market is likely to open on a cautious note as indicated by the GIFT Nifty, which is down by 20 points in early trade currently at 23,703. The muted sentiment comes amid a broader sell-off across Asian markets,

The Nifty 50 concluded the session with a gain of 0.39% at 23,707, while the Sensex wrapped up the session at 78,199, 0.30% higher than the previous close.

Stock Market LIVE today, Stock Market Today, Jan 9, 2025: The stock markets today are expected to open lower amid weakness in global markets. At 6:55 AM, GIFT Nifty index was trading around 66 points down at 23,714 level.

Indian benchmark indices Nifty and Sensex staged a modest recovery on Wednesday, closing slightly in the negative as a rebound in IT stocks provided support. Gains in Reliance Industries lifted the oil and gas sector,

On January 7, the Indian stock market benchmarks, Sensex and Nifty 50, gained even as HMPV virus fears persist.